Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07359911 · ClinicalTrials.gov registry record · NA

Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients

A NA study of Sarcoma, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07359911: Recruiting NA study of Sarcoma, sponsored by University of Miami.

NCT07359911 is a NA study of Sarcoma that is actively recruiting participants, run by University of Miami. The registered enrollment target is 40 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07359911, a NA study of Sarcoma, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects of a multimodal exercise intervention on chemotherapy uptake in newly diagnosed pediatric, adolescent and young adult (AYA) Sarcoma patients.

Primary Outcome

Feasibility will be measured as the percentage of participants that consent and meet eligibility to participate between both the intervention and control arms. Criterion for success: At least (≥) 50% of all eligible participants consent to participate between both arms.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Intervention
  • BEHAVIORAL Usual Care Control
  • BEHAVIORAL Exit Interview

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-02-05
Est. Completion 2027-08-05
Phase NA
University of Miami

721 total trials

What NCT07359911 shows while recruiting

NCT07359911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 3 interventions - of which Exercise Intervention is the first listed.

NCT07359911 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07359911 about?

NCT07359911 is a clinical study titled "Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients". The purpose of this study is to determine the effects of a multimodal exercise intervention on chemotherapy uptake in newly diagnosed pediatric, adolescent and young adult (AYA) Sarcoma patients.

What is the current status of trial NCT07359911?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-05. Estimated completion is 2027-08-05.

What conditions does trial NCT07359911 study?

This clinical trial studies the following conditions: Sarcoma.

What interventions are being tested in trial NCT07359911?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL), Usual Care Control (BEHAVIORAL), Exit Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT07359911?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07359911 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07359911's enrollment target sits among peer trials

40 75th of 122 higher than 46 of 122 other Sarcoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07359911, the US trial registry maintained by the National Library of Medicine. NCT07359911 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.